Literature DB >> 10186890

The failed Patient Self-Determination Act and policy alternatives for the right to die.

J L Yates1, H R Glick.   

Abstract

The empirical evidence regarding the implementation and impact of the federal Patient Self-Determination Act is examined in this article. The Act was designed to increase the use of advance medical directives in light of the U.S. Supreme Court's Cruzan decision. Research shows that the law has had little effect and that the use of advance directives has scant relation to medical treatment and care. Various policy alternatives for the right to die are also examined. The authors conclude with an analysis of the likely impact of medical costs, fruitless treatment, and rationed health care on limiting life-prolonging treatment.

Entities:  

Mesh:

Year:  1997        PMID: 10186890     DOI: 10.1300/j031v09n04_03

Source DB:  PubMed          Journal:  J Aging Soc Policy        ISSN: 0895-9420


  3 in total

1.  Implementing an advance care planning program in German nursing homes: results of an inter-regionally controlled intervention trial.

Authors:  Jürgen In der Schmitten; Katharina Lex; Christine Mellert; Sonja Rothärmel; Karl Wegscheider; Georg Marckmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-24       Impact factor: 5.594

2.  Advance directives in nursing homes: prevalence, validity, significance, and nursing staff adherence.

Authors:  Sarah Sommer; Georg Marckmann; Michael Pentzek; Karl Wegscheider; Heinz-Harald Abholz; Jürgen in der Schmitten
Journal:  Dtsch Arztebl Int       Date:  2012-09-14       Impact factor: 5.594

3.  The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives.

Authors:  Bhumsuk Keam; Young Ho Yun; Dae Seog Heo; Byeong Woo Park; Chi-Heum Cho; Sung Kim; Dae Ho Lee; Soon Nam Lee; Eun Sook Lee; Jung Hun Kang; Si-Young Kim; Jung Lim Lee; Chang Geol Lee; Yeun Keun Lim; Sam Yong Kim; Jong Soo Choi; Hyun Sik Jeong; Mison Chun
Journal:  Support Care Cancer       Date:  2012-12-22       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.